Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new ...

The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of type 1 diabetes, it said on ...

Anavex Life Sciences said European regulators informed it of a negative trend vote related to its application for its blarcamesine treatment of early Alzheimer's disease. The Committee for Medicinal ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the Most Undervalued Long Term Stocks to Buy Right Now. On October 17, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced that the European ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...

Anavex Life Sciences (AVXL) lost ~47% in the premarket on Friday after a group of experts appointed by the EU drug regulator, ...

Please provide your email address to receive an email when new articles are posted on . The recommendation was extended to Vyjuvek, a topical that delivers gene copies that address the root cause of ...